Planet Labs PBC (PL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Apoptotic cell death is regarded as an important pathogenetic mechanism in the major immune-mediated liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis.

Patients with early-stage PBC and ductopenia had reduced biochemical response to ursodeoxycholic acid treatment. Ductopenia is a significant risk factor for worse biochemical profiles and poor ...

Cirrhosis of the liver describes a progressive condition where scar tissue gradually replaces healthy liver tissue. Health experts may classify cirrhosis into two clinical stages: compensated ...

The Kenya Wildlife Service (KWS) and the Public Service Commission (PSC) have announced a variety of job opportunities. Picture of a man and woman smiling during a job interview. Photo: Getty Images.

A diagnosis of AIH, PBC, or PSC in a patient with liver disease always requires careful exclusion of other major causes of liver damage, including alcoholic, viral, drug- and toxin-induced ...

Gilead Sciences’ Livdelzi (seladelpar) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adults with the rare liver disease primary biliary cholangitis (PBC) ...

Share on Pinterest Recent reports on moderate alcohol consumption have left many people wondering whether it’s safe to drink at all. Studio Firma/Stocksy United A new federal report shows that ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 16 January 2025, approved the medicine seladelpar (Livdelzi) in adults for the treatment of a liver illness called Primary ...

LAKE WORTH BEACH, Fla. (CBS12) — As the second semester of school gets underway, CBS12 News is partnering with the Education Foundation of Palm Beach County to collect donations to make sure ...

Combined anti-gp210 and anti-centromeric antibody positivity is an independent marker that could predict a poor prognosis in patients with primary biliary cholangitis (PBC) at the time of diagnosis, ...

A new clinical trial, sponsored by UCL and UCLH, aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile ...